Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI

NCT06009874 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Dapagliflozin 10mg Tab
DRUG: Placebo

Sponsor

Mohammad Hussien Tantawy Soliman